Neumora Corp (NMRA): Operatsion rentabellik

Neumora Therapeutics, Inc. (NMRA) tovar belgisi

Neumora Therapeutics yetakchi neyrobiologlar va ma'lumotlar olimlarini birlashtirgan holda, keng ko'lamli tadqiqot va ishlanmalarga (R&D) investitsiya kiritmoqda. EBIT marjasi samaradorlik dinamikasini aks ettiradi va ushbu ko'rsatkich hozirda 0.00 darajasida. Kompaniya hozirda ilmiy institutlar bilan texnologik ittifoqlar tuzgan holda, klinik sinovlarni mustaqil ravishda olib bormoqda. Moliyaviy muvaffaqiyat shizofreniya va depressiyani davolash uchun aniq tibbiyot vositalarini ishlab chiqishga asoslangan bo'lib, ular keyinchalik davlat tizimlari tomonidan xarid qilinadi.

NMRA: Neumora Therapeutics, Inc. Operatsion marja 21.02.2024 - 20.11.2026

Neumora Therapeutics, Inc. (NMRA) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:Neumora Therapeutics, Inc.
neumoratx.com tayyor mahsulotlari

Ushbu aktivning fundamental tahlili operatsion jarayonlar samaradorligini baholash orqali xavflarni minimallashtirishni talab qiladi. Miya patologiyalari uchun patent himoyasidagi dori vositalarini ishlab chiquvchi Neumora Therapeutics (NMRA) uchun ichki pul oqimini yaratish qobiliyati hal qiluvchi ahamiyatga ega. Operatsion foyda marjasi moliyaviy xarajatlar va soliqlarni hisobga olguncha, asosiy faoliyatdan olingan foyda ulushini ko'rsatadi. Ushbu ko'rsatkich qarz yuklamasining ta'sirisiz biznes modelining haqiqiy samaradorligini o'lchaydi va uning tendentsiyasi uzoq muddatli kapital barqarorligini belgilaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|Sotuvning operatsion rentabelligi prothena.com|Alector Therapeutics (ALEC) - Operatsion rentabellik|Annexon Biosciences Inc. - Operatsion foyda normasi|OMER (Omeros Corp) - Operatsion marja|Operatsion marja neurogene.com|Operatsion marja ACIU|VYGR - Sotuvning operatsion rentabelligi|Operatsion rentabellik Scilex Holding Company, Inc. SCLX|Operatsion foyda bo'yicha marjinallik Tevogen Bio Inc.|ACOG - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Sotuvning operatsion marjasi|Cassava Sciences Inc (SAVA) - Operatsion marja|Sotuvning operatsion marjasi ASRT|Operatsion marja coyatherapeutics.com|Operatsion marja VTGN|Ovid Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Sotuvning operatsion marjasi|ATHE - Operatsion rentabellik|Operatsion faoliyat rentabelligi clene.com CLNN|PEPG: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi JUNS|RLMD (Relmada Corp) - Operatsion marja|Annovis Bio Inc (ANVS) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operatsion foyda normasi|Operatsion rentabellik Klotho Neurosciences KLTO|NRSN: Operatsion foyda bo'yicha sotuv rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi